Literature DB >> 19559337

Treatment guidelines for dialysis catheter-related bacteremia: an update.

Michael Allon1.   

Abstract

Entities:  

Year:  2009        PMID: 19559337      PMCID: PMC4082022          DOI: 10.1053/j.ajkd.2009.04.006

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  30 in total

1.  Clinical practice guidelines for vascular access.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

2.  Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.

Authors:  Zipporah Krishnasami; Donna Carlton; Lisa Bimbo; Maria E Taylor; Daniel F Balkovetz; Jill Barker; Michael Allon
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  Outcome of tunneled hemodialysis catheters placed by radiologists.

Authors:  G B Lund; S O Trerotola; P F Scheel; S J Savader; S E Mitchell; A C Venbrux; F A Osterman
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

4.  Management of bacteremia associated with tunneled-cuffed hemodialysis catheters.

Authors:  G A Beathard
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

5.  Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.

Authors:  Nuria Fernandez-Hidalgo; Benito Almirante; Raquel Calleja; Isabel Ruiz; Ana M Planes; Dolors Rodriguez; Carles Pigrau; Albert Pahissa
Journal:  J Antimicrob Chemother       Date:  2006-04-05       Impact factor: 5.790

6.  Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.

Authors:  Michele H Mokrzycki; Meilin Zhang; Hillel Cohen; Ladan Golestaneh; Jeffrey M Laut; Stuart O Rosenberg
Journal:  Nephrol Dial Transplant       Date:  2006-01-31       Impact factor: 5.992

7.  Use of Permcath (Quinton) catheter in uraemic patients in whom the creation of conventional vascular access for haemodialysis is difficult.

Authors:  T Pourchez; P Morinière; A Fournier; J Pietri
Journal:  Nephron       Date:  1989       Impact factor: 2.847

8.  Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

Authors:  L Feldman; S Efrati; E Eviatar; R Abramsohn; I Yarovoy; E Gersch; Z Averbukh; J Weissgarten
Journal:  Kidney Int       Date:  2007-04-25       Impact factor: 10.612

9.  Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report.

Authors:  Ivan D Maya; Donna Carlton; Erin Estrada; Michael Allon
Journal:  Am J Kidney Dis       Date:  2007-08       Impact factor: 8.860

10.  Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen.

Authors:  Christopher V Poole; Donna Carlton; Lisa Bimbo; Michael Allon
Journal:  Nephrol Dial Transplant       Date:  2004-02-19       Impact factor: 5.992

View more
  15 in total

1.  Clinical management of dialysis catheter-related bacteremia with concurrent exit-site infection.

Authors:  Dmitri Sychev; Ivan D Maya; Michael Allon
Journal:  Semin Dial       Date:  2011 Mar-Apr       Impact factor: 3.455

2.  The spectrum of infections in catheter-dependent hemodialysis patients.

Authors:  Yaser Al-Solaiman; Erin Estrada; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

3.  Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

Authors:  Daniel L Landry; Gregory L Braden; Stephen L Gobeille; Sarah D Haessler; Chirag K Vaidya; Stephen J Sweet
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

4.  Optimal Approach for the Diagnosis of Hemodialysis Catheter-Related Bacteremia.

Authors:  Tanya S Johns; Michele H Mokrzycki
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 8.237

5.  Arteriovenous graft placement in predialysis patients: a potential catheter-sparing strategy.

Authors:  Roman Shingarev; Ivan D Maya; Jill Barker-Finkel; Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-04-02       Impact factor: 8.860

6.  Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: a single-center experience.

Authors:  Maria E Taylor; Michael Allon
Journal:  Am J Kidney Dis       Date:  2010-06       Impact factor: 8.860

7.  Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism.

Authors:  Crystal A Farrington; Michael Allon
Journal:  Am J Nephrol       Date:  2019-06-26       Impact factor: 3.754

8.  Peripherally inserted central catheters and other intravascular devices: how safe are they for hemodialysis patients?

Authors:  Roman Shingarev; Michael Allon
Journal:  Am J Kidney Dis       Date:  2012-10       Impact factor: 8.860

9.  Evaluating Approaches for the Diagnosis of Hemodialysis Catheter-Related Bloodstream Infections.

Authors:  Friederike Quittnat Pelletier; Mohammad Joarder; Susan M Poutanen; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 8.237

10.  Racial and Sex Disparities in Catheter Use and Dialysis Access in the United States Medicare Population.

Authors:  Shipra Arya; Taylor A Melanson; Elizabeth L George; Kara A Rothenberg; Manjula Kurella Tamura; Rachel E Patzer; Jason M Hockenberry
Journal:  J Am Soc Nephrol       Date:  2020-01-15       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.